Post by
Noteable on Jul 13, 2023 1:17pm
Inflation Reduction Act (IRA) boosts biological drugs
"This means that biologics will be less affected by the IRA compared to small molecule drug development, which in turn could impact decisions on biotech financing going forward....
... The IRA may impact revenues resulting in reduced investments in (in-house small molecule) R&D, but further biopharmaceutical collaborations may help to support future innovation by mitigating costs as interest rates continue to rise."
https://www.pharmaceutical-technology.com/comment/inflation-reduction-biologic-drug-venture/
Comment by
Noteable on May 13, 2024 12:04pm
mRNA vaccines are synthetically manufactured and although their biological mechanism of action and immune response are similar to biologics, they would appear to fall under the small molecule 9 years of exclusivity under the recently passed IRA. https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36036952 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012156/
Comment by
Noteable on May 14, 2024 9:36am
"The Wod is Getting Out !"
Comment by
Noteable on May 14, 2024 9:39am
Should read: " The Word is Getting Out !" - And you can only hear what has been said if you were actually listening.
Comment by
Noteable on Mar 08, 2024 12:40pm
https://www.forbes.com/sites/joshuacohen/2023/10/02/inflation-reduction-act-may-curb-patent-practices-that-forestall-market-entry-of-biosimilars/?sh=63365c4f4e30
Comment by
Noteable on Mar 09, 2024 12:40pm
December 2023 - The Federal Trade Commission (FTC) scuttles Sanofi’s small molecule licensing deal with Maze Therapeutic - further pointing to the Federal Government's expicit intent to boost biological drug development and commercilization through the IRA. https://www.fiercebiotech.com/biotech/sanofi-scraps-maze-deal-after-ftc-throws-antitrust-obstacles
Comment by
Noteable on Mar 12, 2024 11:21am
Pearl Bio's whiteboards ideas have been developed over 15 years. Pearl is pioneering a new era of biotherapeutic design by seeking enabling access to potential new disease targets and the putative evolution of entirely new classes of molecules. Today MSD has announced it has decided to invest US$1 Billion in this start-up pseud0-biologicis company.
Comment by
Noteable on Mar 12, 2024 6:27pm
Thermo Fisher Scientific will divest its anatomical pathology business for $1.1 billion to PHC Holdings. The sale leaves Thermo Fisher in a competitive M&A position among bioprocessing peers, says an analyst.
Comment by
Noteable on Apr 29, 2024 12:45pm
In September 2023, Abbvie terminated its relationship with I-Mab to develop a cancer drug. https://www.reuters.com/markets/deals/abbvie-terminates-deal-with-i-mab-develop-cancer-drug-2023-09-22/
Comment by
Noteable on Mar 13, 2024 7:37pm
https://www.biospace.com/article/ira-drives-pfizer-s-decision-to-focus-on-biologics-not-small-molecules/
Comment by
Noteable on Mar 19, 2024 11:01am
The Indian pharmaceutical industry is generally risk-averse and Indian innovative research has a high risk of failure.
Comment by
Noteable on May 06, 2024 11:24am
https://www.biospace.com/article/drug-companies-vcs-rethink-r-and-d-strategies-as-ira-stands-strong-in-court/
Comment by
Noteable on May 06, 2024 12:07pm
May 06, 2024 - Bank of America Corp. and BNP Paribas SA are on the verge of winning lead roles arranging US$20 Billion Sanofi’s separation of its consumer-health business. https://www.bnnbloomberg.ca/bofa-bnp-poised-to-win-lead-roles-on-20-billion-sanofi-spinoff-1.2069321
Comment by
Noteable on Jun 22, 2024 1:19pm
June 20, 2024 - "“As dealmakers become more comfortable with regulatory uncertainty, we’ve seen dealmakers increasingly focused on deals in the $5 billion to $15 billion range rather than in large-scale transformative M&A,” Roel Van den Akker, PwC’s Pharma and Life Sciences Seals Lead, said https://stockhouse.com/companies/bullboard?symbol=t.onc&postid=36097745
Comment by
Noteable on Jun 22, 2024 7:13pm
https://stockhouse.com/companies/bullboard?symbol=t.onc&postid=36097745
Comment by
Jf4270393 on May 01, 2024 8:08pm
Thank you Noteable for your knowledge and informative information. I am not sure of your background, you allways presnt new material. Cheers!!
Comment by
ENEMENEMYNEMO on May 01, 2024 8:20pm
Seriously??? He adds no more to this board than I do. Google "Immune"...cut 'n paste...repeat. I'd rather read Canfans manifestos.
Comment by
Peladawn on May 02, 2024 8:52am
Hmmm, Lets see..Notable adds vast amounts of pertinent info and technical knowledge, on a daily basis, and you add lies, insults and disruption.. Im pretty sure Id have to say notable adds more to this boardreal close though.
Comment by
Buckhenry on May 02, 2024 11:44am
I think the pumpers definition of pertinent is not pertinent!!!
Comment by
Azzak34 on May 02, 2024 12:32pm
Who are you talking to when you post? It's almost like your referencing us "pumpers" to someone else. I think we should all start calling you and the other simpletons the "dumpers". Several meanings to the dumpers and they're all pretty apt.
Comment by
ENEMENEMYNEMO on May 02, 2024 12:44pm
The term Pumpers too... which I'm sure you're waiting for your mom to go get your pop tarts before you start.
Comment by
Azzak34 on May 02, 2024 12:55pm
Booooo! You already did the mom pop tarts one. I don't get the connection, unless you're implying some sort of incestuous relationship between me, my mother and pop tarts!?!
Comment by
Azzak34 on May 02, 2024 1:13pm
Wait, that was what you were getting at? That kind of carry on is illegal where I'm from, I suspect where you're from too. Isn't coercing someone to commit a crime, in itself a crime?
Comment by
Azzak34 on May 02, 2024 2:08pm
It's 2024 amd you're doing mom jokes? I think on a biotech stock board we can dispense with that kind of humor. So why don't we get off moms? I just got off yours.
Comment by
ENEMENEMYNEMO on May 02, 2024 2:11pm
Beat me to that one...she probably would be up for it though.
Comment by
Azzak34 on May 02, 2024 2:16pm
Don't be upset about it, you have a disadvantages you're having to overcome! Ah well that's no good, what happened?
Comment by
Buckhenry on May 02, 2024 2:17pm
I think this discussion is much more "pertinent " than the usual and paste posts ....
Comment by
Azzak34 on May 02, 2024 2:21pm
Again Buckster that's why you're never going to get any smarter. Against all odds you manage to stay suspended in stupid stasis despite the dirth of info posted here almost daily. Take a few days off from here and educate yourself a bit. Come back to us with your findings. I'll bring the crayons.
Comment by
Buckhenry on May 02, 2024 3:57pm
I prefer the box of 64 crayons... they only gave azzak the box of 8 cause he kept eating them. But he has finally graduated to the first grade after 3 attempts at kindergarten... he got to big to fit in the desk.
Comment by
Azzak34 on May 02, 2024 4:02pm
Way to take my joke and make it unfunnier you silly Dumper. "Too" big. To big doesn't make sense. Weren't you threatening to double down on your buffoonery Buck? I haven't noticed a significant uptick in the moron stakes, just the standard level we're all used "to".
Comment by
Buckhenry on May 02, 2024 4:21pm
Azzak just don't get it. You could block and never see our post but you choose to respond idiotcally and then we just have fun at your expense. Since we seem to be in a loooong wait and see here there is really nothing new to say on this stock so we make fun of you in the interim.
Comment by
ENEMENEMYNEMO on May 02, 2024 5:08pm
That made me laugh. Blood Type D-
Comment by
Noteable on May 15, 2024 3:02pm
Should readf: '...ONCY would likely choose the "Orphan Drug" Accelerated Approval pathway for pelareorep in the pancreatic cancer indications..." and the "unmet treatment need" Accelerated Approval pathway for the rest of the indictions that pelareorep would seek approval in.
Comment by
Noteable on Mar 19, 2024 11:39am
ONCY's novel scalable, flexible and reliable biomanufacturing patent for pelareorep is effective until at least 2031, after which further biomanufacturing patent extensions can be applied and become effective.
Comment by
Noteable on Mar 19, 2024 6:19pm
The Biosecure Act provides that : " .... the restrictions would also apply to any entity owned by, controlled by, or subject to the jurisdiction or direction of a country of concern as well as any person “knowingly causing or directing, directly or indirectly, a violation” of the regulations."
Comment by
Noteable on Mar 19, 2024 6:22pm
.... so goodbye to Andrew de G.
Comment by
Noteable on Mar 19, 2024 7:09pm
Should read : " On February 06, & February 07, 2024 a combined total of approximately 3.74 million shares of ONCY were sold on the NASDAQ and approximately 675K on the TSX ..."
Comment by
Noteable on Mar 26, 2024 8:39pm
" On February 06, & February 07, 2024 a combined total of approximately 3.74 million shares of ONCY were sold on the NASDAQ and approximately 675K on the TSX ..." On February 08, 2024 this happened ... https://www.reuters.com/markets/deals/trumps-media-deal-partner-nears-50-million-financing-sources-2024-02-08/
Comment by
Peladawn on Jun 19, 2024 9:43am
lol....an article from New York Magazine!....the leftist of the left.... ...."Steele Dossier was 'Case Study' in Journalistic Manipulation"..... https://nymag.com/intelligencer/2021/07/steele-dossier-was-case-study-in-journalistic-manipulation.html
Comment by
Noteable on Jun 15, 2024 10:20am
In FY 2023 total government deficit was reduced to US $1.70 Trillion.
Comment by
Noteable on Jun 15, 2024 11:34am
April 2024 - https://www.bloomberg.com/news/articles/2024-04-25/us-says-china-moving-too-slowly-on-protecting-intellectual-property
Comment by
Noteable on Jun 15, 2024 11:58am
https://stockhouse.com/companies/bullboard/t.onc/oncolytics-biotech-inc?postid=36090531